Cogent Biosciences (COGT) News Today $5.32 -0.19 (-3.36%) As of 02:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock COGT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Cogent Biosciences (NASDAQ:COGT) Stock Price Up 11.6% After Analyst UpgradeCogent Biosciences (NASDAQ:COGT) Shares Up 11.6% After Analyst UpgradeMay 30 at 12:40 PM | marketbeat.comJPMorgan Chase & Co. Issues Positive Forecast for Cogent Biosciences (NASDAQ:COGT) Stock PriceJPMorgan Chase & Co. upped their price target on shares of Cogent Biosciences from $21.00 to $25.00 and gave the company an "overweight" rating in a report on Thursday.May 30 at 11:17 AM | marketbeat.comDeutsche Bank AG Reduces Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Deutsche Bank AG reduced its holdings in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 51.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 79,265 shares of the technology company's stock after selling 83,593 sMay 30 at 3:23 AM | marketbeat.comCogent Biosciences Announces Participation in the Jefferies Global Healthcare ConferenceMay 29 at 8:00 AM | globenewswire.comAnalysts Set Cogent Biosciences, Inc. (NASDAQ:COGT) PT at $14.29May 26, 2025 | americanbankingnews.comBNP Paribas Financial Markets Buys Shares of 66,784 Cogent Biosciences, Inc. (NASDAQ:COGT)BNP Paribas Financial Markets bought a new position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 66,784 shares of the technology company's stock, valuMay 26, 2025 | marketbeat.comResearch Analysts Set Expectations for COGT Q2 EarningsCogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Equities research analysts at HC Wainwright upped their Q2 2025 earnings per share estimates for Cogent Biosciences in a report released on Tuesday, May 20th. HC Wainwright analyst R. Burns now expects that the technology company will post eaMay 24, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for COGT EarningsMay 24, 2025 | americanbankingnews.comHC Wainwright Lowers Cogent Biosciences (NASDAQ:COGT) Price Target to $12.00May 23, 2025 | americanbankingnews.comD. E. Shaw & Co. Inc. Sells 117,240 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)D. E. Shaw & Co. Inc. reduced its position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 25.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 339,988 shares of the technology company'sMay 22, 2025 | marketbeat.comNorthern Trust Corp Grows Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Northern Trust Corp boosted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 7.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 912,713 shares of the technology company's stocMay 22, 2025 | marketbeat.comTema Etfs LLC Takes Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Tema Etfs LLC bought a new stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 51,926 shares of the technology company's stock, valued at apMay 21, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) have received an average recommendation of "Moderate Buy" from the eight research firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, four have assignedMay 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Reduces Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Point72 Asset Management L.P. lowered its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 48.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,347,302 shares of the technologMay 18, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Holdings Raised by Paradigm Biocapital Advisors LPParadigm Biocapital Advisors LP grew its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 6.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,917,412 shares of the technology company's stock after purchasing an addMay 16, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) is Octagon Capital Advisors LP's 8th Largest PositionOctagon Capital Advisors LP raised its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 111.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,763,000 shares of the technology company's stock after pMay 15, 2025 | marketbeat.comQ2 EPS Estimate for Cogent Biosciences Lifted by AnalystCogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Investment analysts at Leerink Partnrs boosted their Q2 2025 earnings estimates for Cogent Biosciences in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst A. Berens now anticipates that the technology company will post eaMay 13, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Deerfield Management Company L.P. Series CDeerfield Management Company L.P. Series C decreased its position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 29.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,631,000 shares of thMay 10, 2025 | marketbeat.comAlgert Global LLC Has $2.69 Million Stake in Cogent Biosciences, Inc. (NASDAQ:COGT)Algert Global LLC lifted its stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 92.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 344,235 shares of the technology company's stock after purchasingMay 10, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Issues Earnings ResultsCogent Biosciences (NASDAQ:COGT - Get Free Report) announced its earnings results on Tuesday. The technology company reported ($0.52) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.03.May 8, 2025 | marketbeat.comCogent Biosciences Reports First Quarter 2025 Financial ResultsMay 6, 2025 | globenewswire.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Invesco Ltd.Invesco Ltd. lessened its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 92.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,641 shares of the technology company's stock after sellMay 6, 2025 | marketbeat.comLeerink Partnrs Has Strong Forecast for COGT FY2026 EarningsCogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Research analysts at Leerink Partnrs raised their FY2026 earnings estimates for Cogent Biosciences in a report released on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the technology company will post earnings ofMay 3, 2025 | marketbeat.comCogent Biosciences (COGT) to Release Quarterly Earnings on TuesdayCogent Biosciences (NASDAQ:COGT) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-cogent-biosciences-inc-stock-1/)May 1, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading 3.8% Higher - Here's What HappenedCogent Biosciences (NASDAQ:COGT) Trading 3.8% Higher - What's Next?April 30, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Bought by Nantahala Capital Management LLCNantahala Capital Management LLC increased its holdings in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 7.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 852,855 shares of the technology company's stock after buying an additional 61,919 sharesApril 30, 2025 | marketbeat.comRenaissance Technologies LLC Makes New Investment in Cogent Biosciences, Inc. (NASDAQ:COGT)Renaissance Technologies LLC bought a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 242,929 shares of the technology compApril 28, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Acquired by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. increased its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 5.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,300,000 shares of the technology compApril 27, 2025 | marketbeat.comCogent Biosciences appoints Ray Frost as SVP, Market AccessApril 26, 2025 | markets.businessinsider.comCogent to present preclinical data from pipeline programs at AACR meetingApril 26, 2025 | markets.businessinsider.comCogent Biosciences, Inc. (NASDAQ:COGT) Receives Consensus Rating of "Moderate Buy" from BrokeragesCogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight ratings firms that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, four have assigned aApril 26, 2025 | marketbeat.comCogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New LeadersApril 25, 2025 | globenewswire.comSilverarc Capital Management LLC Has $7.19 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)Silverarc Capital Management LLC cut its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 24.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 921,137 shares of the technology company's stock aftApril 24, 2025 | marketbeat.comDiadema Partners LP Acquires New Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Diadema Partners LP purchased a new stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 90,000 shares of the technology company's stock, valued at approximately $702,000. Diadema Partners LP owApril 24, 2025 | marketbeat.comXTX Topco Ltd Takes $457,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT)XTX Topco Ltd acquired a new position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 58,560 shares of the technology company's stock, valued at appApril 23, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading Down 7.6% - Should You Sell?Cogent Biosciences (NASDAQ:COGT) Trading Down 7.6% - Here's WhyApril 18, 2025 | marketbeat.comWalleye Capital LLC Boosts Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Walleye Capital LLC lifted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 68.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 936,791 shares of the technApril 18, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Shares Up 6.1% - Time to Buy?Cogent Biosciences (NASDAQ:COGT) Stock Price Up 6.1% - Still a Buy?April 17, 2025 | marketbeat.comAlliancebernstein L.P. Buys 382,882 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)Alliancebernstein L.P. lifted its position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 466.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 464,942 shares of the technology companyApril 16, 2025 | marketbeat.comFmr LLC Boosts Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)Fmr LLC grew its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 99.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,569,256 shares of the technology company's stocApril 15, 2025 | marketbeat.comVanguard Group Inc. Purchases 418,975 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)Vanguard Group Inc. grew its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 7.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,133,380 shares of the technology company's stock after buyiApril 14, 2025 | marketbeat.comTrexquant Investment LP Grows Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)Trexquant Investment LP boosted its holdings in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 184.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 277,523 shares of the technology company's stock after buying an additional 179,9April 11, 2025 | marketbeat.comFranklin Resources Inc. Raises Stake in Cogent Biosciences, Inc. (NASDAQ:COGT)Franklin Resources Inc. boosted its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 28.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,283,673 shares of the technology company's stock after buyApril 11, 2025 | marketbeat.comCogent: Several 2025 Readouts On Deck With Bezuclastinib AdvancementApril 9, 2025 | seekingalpha.comCogent Biosciences (NASDAQ:COGT) Sets New 52-Week Low - Time to Sell?Cogent Biosciences (NASDAQ:COGT) Reaches New 52-Week Low - Time to Sell?April 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Takes $4.28 Million Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Springhill Fund Asset Management HK Co Ltd acquired a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 548,554 shares of the technology company'April 8, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Cinctive Capital Management LPCinctive Capital Management LP trimmed its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 87.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 40,643 shares of the technology company's stock after selling 289,776 shares during the qApril 6, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Reaches New 52-Week Low - Here's WhyCogent Biosciences (NASDAQ:COGT) Hits New 52-Week Low - What's Next?April 2, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Stock Price Down 7.7% - Time to Sell?Cogent Biosciences (NASDAQ:COGT) Shares Down 7.7% - Should You Sell?April 1, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight analysts that are covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, four have issued a buy recMarch 31, 2025 | marketbeat.com Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address COGT Media Mentions By Week COGT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COGT News Sentiment▼1.050.88▲Average Medical News Sentiment COGT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COGT Articles This Week▼93▲COGT Articles Average Week Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Apellis Pharmaceuticals News Mirum Pharmaceuticals News Arrowhead Pharmaceuticals News Vericel News Kiniksa Pharmaceuticals News Harmony Biosciences News Denali Therapeutics News Belite Bio News CG Oncology News NewAmsterdam Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COGT) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COGT Stock Free COGT Stock Alerts